Flagship explainer
What drives AMNEAL PHARMACEUTICALS, INC.’s return on equity?
ROE is five filed business factors multiplied together.
| Input | Value | Fiscal year | Source |
|---|---|---|---|
| $72.1M | FY2025 |
| |
| Income before tax | $139M | FY2025 |
|
| Operating income | $394M | FY2025 |
|
| $3.0B | FY2025 |
| |
| Ending assets | $3.7B | FY2025 |
|
| Beginning assets | $3.5B | FY2024 |
|
| −$70.8M | FY2025 |
| |
| −$109M | FY2024 |
|
Source:
- SEC filingFiling detailsAccession 0001723128-26-000011